3 Biotech Stocks to Pad Your Portfolio with if the Market Crashes
Celgene Corp. (NASDAQ:CELG), Regeneron Pharmaceuticals (NASDAQ:REGN), and Gilead Sciences (NASDAQ:GILD) aren't immune to broader market pops and drops, but their track records for developing top-selling drugs is envy-inspiring, and that may make picking up their shares in a tumbling tape savvy.
No. 1: Targeting cancer care
When you're diagnosed with a life-threatening disease like cancer, you're unlikely to forgo treatment because of uncertain economic times. As a result, cancer-drug maker Celgene Corp (NASDAQ:CELG) isn't likely to see its sales or profit nosedive because markets take a breather, or the economy stumbles.
No. 1: Targeting cancer care
When you're diagnosed with a life-threatening disease like cancer, you're unlikely to forgo treatment because of uncertain economic times. As a result, cancer-drug maker Celgene Corp (NASDAQ:CELG) isn't likely to see its sales or profit nosedive because markets take a breather, or the economy stumbles.